Merck's Keytruda likely to benefit from 'celebrity effect' after Jimmy Carter declared free of cancer

Former President Jimmy Carter has been declared free of cancer after receiving Merck's ($MRK) Keytruda and radiation therapy for his metastasized melanoma, and research shows that Merck is likely to get a boost in sales as a result. A number of studies have documented a proven celebrity effect in healthcare. One study showed after journalist Katy Couric had an on-air colonoscopy, there was a 21% increase in colorectal screenings the next month. Singer Kylie Minogue's breast cancer diagnosis was later linked to mammography screening increases of 40% in Australia. More from FiercePharmaMarketing

Suggested Articles

With U.S. presidential and congressional campaigns in full swing, it’s not just Americans anxiously awaiting the results of the upcoming elections.

Sun Pharma has recalled one lot of its generic metformin after finding high levels of the probable carcinogen NDMA in tested lots.

Six months after WHO declared a pandemic, the list of drugs proven to work against the virus remains short. Now, Fujifilm has added its drug Avigan.